[Long chronic course of hemiparkinson-plus with l-dopa maintained response].
OBJECTIVE AND CLINICAL CASE: We describe and present a video film of a patient with a hemiparkinsonian illness associated with hemidystonia and pyramidalism, which responded to continuous L-Dopa treatment for twenty years, with no fluctuation or deterioration at the end of the dose-effect. CT and MR studies were normal.


CONCLUSIONS
The characteristics of this case with probable static unilateral dysfunction, basically presynaptic, of the nigrostriate via, make it reasonable to include it in the hemiparkinson-hemiatrophy group.
Arias
M
M
Hospital de Conxo, Complejo Hospitalario Universitario de Santiago, Departamento de Medicina, Universidad de Santiago de Compostela, España.
Requena
I
I
Lema
C
C
D000368:Aged; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D018450:Disease Progression; D004305:Dose-Response Relationship, Drug; D004421:Dystonia / Q000150:complications; D007839:Functional Laterality; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use*; D008297:Male; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy*
D000978:Antiparkinson Agents; D007980:Levodopa